Core Laboratories Inc Stock Price, News & Analysis

Core Laboratories (NYSE: CLB) reported Q1 2025 results with revenue of $123.6 million, declining 4% sequentially and 5% year-over-year. Operating income was $4.4 million, while operating income ex-items reached $11.8 million with 10% margins. The company posted GAAP EPS of $0.00 and EPS ex-items of $0.14.

Key financial highlights include:

• Free cash flow of $3.9 million, up over 50% year-over-year
• Net debt reduced by $4.9 million, maintaining a leverage ratio of 1.31
• Repurchased 131,598 shares worth $2.0 million
• Quarterly dividend of $0.01 per share announced

Performance was impacted by seasonal declines, geopolitical conflicts, expanded sanctions, and pending tariffs. The company's Reservoir Description segment revenue was $80.9 million, while Production Enhancement posted revenue of $42.7 million. For Q2 2025, Core Lab projects revenue between $128-134 million with operating income of $13.1-15.7 million.

Core Laboratories (NYSE: CLB) has scheduled its first quarter 2025 earnings conference call for April 24, 2025, at 7:30 a.m. CDT / 8:30 a.m. EST. The company will release its earnings report after market close on April 23, 2025.

The conference call will feature Larry Bruno (Chairman and CEO), Chris Hill (CFO), and Gwen Gresham (SVP Corporate Development and Investor Relations) discussing financial and operational results. Investors can access the webcast through the company's website, with replay and transcript available after the call.

Core Laboratories operates in over 70 offices across more than 50 countries, providing reservoir description and production enhancement services for the petroleum industry.

Core Laboratories (CLB) reported Q4 2024 revenue of $129.2M, down 4% sequentially but slightly up year-over-year, with operating income of $14.2M. Q4 GAAP EPS was $0.15, while EPS ex-items reached $0.22. The company generated strong free cash flow of $16.2M, up over 50% sequentially.

For full year 2024, revenue increased 3% to $523.8M, with operating income ex-items of $65.3M, up 7%. Full year EPS ex-items grew 9% to $0.87. The company reduced its net debt by $42M during 2024, achieving a debt leverage ratio of 1.31.

The Reservoir Description segment, representing 80% of international revenue, posted Q4 revenue of $86.8M, while Production Enhancement recorded $42.4M. During Q4, CLB repurchased 264,982 shares for $4.9M and maintained its quarterly dividend of $0.01 per share.

Core Laboratories (NYSE: CLB) has announced its fourth quarter 2024 earnings conference call schedule. The call will take place on January 30, 2025, at 7:30 a.m. CST / 8:30 a.m. EST, featuring CEO Larry Bruno, CFO Chris Hill, and SVP Corporate Development Gwen Gresham. The earnings release will be published after market close on January 29, 2025.

The company will provide a listen-only webcast through their website, with replay and transcript available afterward. Core Laboratories operates as a leading provider of reservoir description and production enhancement services, maintaining over 70 offices across more than 50 countries, serving all major oil-producing regions globally.

Core Laboratories (NYSE: CLB) reported strong Q3 2024 results with revenue of $134.4 million, up 3% sequentially and 7% year-over-year. Operating income reached $19.8 million, with operating margins ex-items of 14%, up 100 basis points sequentially. The company achieved $0.25 EPS and generated $10.4 million in free cash flow. Net debt was reduced by $11.8 million, bringing the debt leverage ratio to 1.47. Reservoir Description revenue grew to $88.8 million, while Production Enhancement posted $45.6 million. The company continues to expand internationally and in Carbon Capture and Sequestration projects, despite some headwinds from geopolitical conflicts and weather-related delays.

Core Laboratories (NYSE: CLB) has announced its third quarter 2024 conference call, scheduled for October 24, 2024 at 7:30 a.m. CDT / 8:30 a.m. EDT. The webcast will feature Larry Bruno (Chairman and CEO), Chris Hill (CFO), and Gwen Gresham (SVP Corporate Development and Investor Relations) discussing financial and operational results. An earnings press release will be issued after market close on October 23rd.

Participants can access the live webcast through the company's website at www.corelab.com. A Podcast and replay will be available following the call. For telephone access, contact Lena Brennan at lena.brennan@corelab.com for dial-in information.

Core Laboratories is a leading provider of reservoir description and production enhancement services, with over 70 offices in more than 50 countries worldwide.

Core Laboratories Inc. (NYSE: CLB) reported Q2 2024 revenue of $130.6 million, up slightly sequentially and year-over-year. Operating income was $16.0 million, or $16.4 million ex-items, up 10% sequentially and 5% year-over-year. GAAP EPS was $0.19, or $0.22 ex-items, up 16% sequentially and 5% year-over-year. Free cash flow improved to $14.3 million, and net debt was reduced by $15.8 million.

Reservoir Description revenue grew 2% sequentially to $86.3 million, while Production Enhancement revenue slightly decreased to $44.3 million. The company maintains a constructive outlook on international upstream projects for 2024 and anticipates sustainable client activity growth in the years ahead.

Core Laboratories (NYSE: CLB) will host its second quarter 2024 conference call on July 25, 2024, at 7:30 a.m. CDT / 8:30 a.m. EDT. CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham will discuss the company's financial and operational results. The earnings press release will be available on Core's website after market close on July 24, 2024. To participate in the live webcast, visit www.corelab.com at least fifteen minutes before the call starts. A podcast and replay will be available on the company's website shortly after the call and will remain for 10 days. For phone access, contact Lena Brennan at lena.brennan@corelab.com for the dial-in number.